ArticlePharmaceuticals (Basel, Switzerland)2025
Identification of Potential Pteridin Reductase-1 Inhibitors for the Treatment of Leishmaniasis: A Bioinformatics Approach.
Paulo R da S R Júnior, Lúcio R de Lima, Luciane B Silva, Ryan S Ramos, Vitor H da S Sanches, Njogu M Kimani, Gustavo H G Trossini, Joaquín M Campos, Cleison C Lobato, Cleydson B R Santos
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Paulo R da S R JúniorGraduate Program in Pharmaceutical Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.
Lúcio R de LimaLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.
Luciane B SilvaLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.
Ryan S RamosLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.ORCID 0000-0003-1802-1320 Vitor H da S SanchesLaboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.
Njogu M KimaniNatural Product Chemistry and Computational Drug Discovery Laboratory, Department of Physical Sciences, University of Embu, Embu P.O. Box 6-60100, Kenya.ORCID 0000-0002-5171-1940 Gustavo H G TrossiniLaboratory of Integration Techniques Experimental and Computational in Drug Design, Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, SP, Brazil.ORCID 0000-0003-3634-2531 Joaquín M CamposDepartment of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Campus of Cartuja, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-9035-8123 Cleison C LobatoGraduate Program in Pharmaceutical Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.ORCID 0000-0003-2213-239X Cleydson B R SantosGraduate Program in Pharmaceutical Sciences, Federal University of Amapá, Macapá 68902-280, AP, Brazil.ORCID 0000-0002-0271-335X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Leishmania majormethotrexatemolecular dockingpteridine reductase-1virtual screening
Identifiers
PMID40872625
PMCPMC12389166
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390